Regenerative Medicine Market by technology (Cell Therapy, Gene Therapy, Tissue Engineering, Small Molecules & Biologics), Material (Biodegradable Synthetic Polymers, Scaffold, Artificial Vascular Graft Materials, Hydrogel Material, Collagen, Xenogeneic Material, Deoxyribonucleic Acid Transfection Vectors, Genetically Manipulated Cells Three-Dimensional Polymer Technology, Transgenic, Fibroblasts, Neural Stem Cells Gene-Activated Matrices, Small Molecules, and Biologics) and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology and Others) - Global Opportunity Analysis and Industry Forecasts, 2014 - 2022

  • ALL665024
  • 145 Pages
  • August 2016
  • Healthcare

Regenerative medicines hold the ability to replace, repair, and regenerate tissues and organs that are affected due to some disease, injury, or natural ageing process. These medicines are capable of restoring the functionality of tissues & cells applicable in a wide range of degenerative disorders such as neurodegenerative diseases, dermatology, cardiovascular and orthopedic applications. Researchers have been focusing on the development of advanced technologies based on genes, biologics, somatic cells and stem cells. Stem cells have the capability to proliferate and differentiate owing to which they are of importance in this field. Currently, predominant treatments available for degenerative or life-threatening diseases do not provide a treatment or are palliative; however, regenerative medicines have the ability to replace or regenerate the tissues and organs suffering from injury or disease. Moreover, the exploitation of nano-materials in drug delivery, wound care and immunomodulation are opportunistic for the regenerative medicine market.

The growth of this market is attributed by the factors such as an emergence of stem cell technology, valuable potential of nanotechnology, rising prevalence of chronic diseases & trauma emergencies, innovation in monitoring devices and surgical technologies. Moreover, rising incidence of degenerative diseases specifically and shortage for organ transplants has boosted the market growth. Furthermore, the increasing focus on stem cells with new source, and getting core competency in the emerging economies are expected to supplement the growth in future. The developing nations are adopting technological advanced treatment modalities at a rapid pace, which is expected to assist in the market expansion worldwide. However, operational inefficiency, stringent regulations, and the high cost of the treatment through regenerative medicine deters the market progression.

The report segments the world regenerative medicine market based on product type, material, application, and geography. Based on product type, it is categorized into cell therapy, gene therapy, tissue engineering, and small molecules & biologics. Cell therapy dominated the market among all other products owing to its efficiency to restore the lost function of any tissue or organ. However, the small molecules & biologics segment is anticipated to grow at a highest CAGR of 34.2% from 2016 to 2022, due to its potential to stimulate dormant or endogenous cells to regain their regenerative properties.

Based on material, the market is classified into synthetic materials, biologically derived materials, genetically engineered materials, and pharmaceuticals. The world regenerative medicine market is expected to reach $30,237 million by 2022 at a CAGR of 33.1% during 2016-2022. These materials are further subcategorized into different segments. The biologically derived materials accounted for about 4/7th of total market share in 2015, and is estimated to retain its position during the analysis period. The increasing demand for genetically engineered materials specially due to their unique properties such as promotion of increased proliferation, cellular interactions, and differentiation of cells that facilitates self-assembly into organized structures, and controlling the manipulation of cellular behavior.

On the basis of application, Regenerative medicine market is segmented as cardiovascular, oncology, dermatology, musculoskeletal, wound healing, ophthalmology, neurology, and others. The musculoskeletal application accounted for the largest share in 2015, whereas cardiovascular is expected to be the fastest growing segment at a CAGR of 35.3% during the analysis period.

Geographically, the market is divided into North America, Europe, Asia-Pacific, and LAMEA regions. North America is projected to dominate the overall market owing to the rising incidence of chronic disorders, growing demand for artificial organs due to the rise in the cases of organ failure, and presence of highly sophisticated healthcare infrastructure. Asia-Pacific is projected to emerge as the region with maximum growth potential, with a CAGR of 39.9% during the forecast period, due to the presence of high unmet medical needs and persistently improving healthcare infrastructure. In addition, chief countries such as India, China, Australia and Japan contribute to the market growth due to high population base, rising demand for tissue-engineered and regenerative medicine products. These countries have varying demographic and cultural conditions, which highly influence their respective markets.

Key players operating in the regenerative medicine market include Stryker Corporation, Zimmer Biomet Holdings, Inc., Medtronic plc, Baxter International Inc., DePuy Synthes, Organogenesis Inc. (Advanced Biohealing), Integra Lifesciences Holdings Corporation, Acelity Holdings, Inc., Ocata Therapeutics Inc. (Astellas Pharma Inc.), and CryoLife Inc.

Key Benefits

  • The report includes an extensive analysis of the factors driving as well as restraining the world regenerative medicine market.
  • The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
  • The report provides a quantitative analysis from 2014 to 2022 that is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • Extensive analysis by product, material, application, and geography helps in understanding the various types of devices used for different chronic abnormalities.
  • Competitive intelligence highlights the business practices followed by leading market players across various geographic regions.

Key Market Segments:


  • Cell Therapy
  • Gene Therapy
  • Tissue Engineering
  • Small Molecules & Biologics


  • Synthetic Materials
    • Biodegradable Synthetic Polymers
    • Scaffold
    • Artificial Vascular Graft Materials
    • Hydrogel Material
  • Biologically Derived Materials
    • Collagen
    • Xenogeneic Material
  • Genetically Engineered Materials
    • Deoxyribonucleic Acid Transfection Vectors
    • Genetically Manipulated Cells
    • Three-Dimensional Polymer Technology
    • Transgenic
    • Fibroblasts
    • Neural Stem Cells
    • Gene-Activated Matrices
  • Pharmaceuticals
    • Small Molecules
    • Biologics


  • Cardiovascular
  • Oncology
  • Dermatology
  • Musculoskeletal
  • Wound Healing
  • Ophthalmology
  • Neurology
  • Others


  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Taiwan
    • Rest of Asia-Pacific
    • Brazil
    • Turkey
    • Venezuela
    • Saudi Arabia
    • Republic of South Africa
    • Rest of LAMEA
Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+91 20 66346066
--- or ---



World Radiology Information Systems Market - Opportunities and Forecasts, 2014 - 2020

Radiology information system is defined as networked software solution, which manages medical imagery and related information. The system further helps in managing critical radiological data as well as information in ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370


World Bioburden Testing Market - Opportunities and Forecasts, 2015 - 2020

Bioburden testing is a process of measuring viable microorganisms on medical devices, raw material, or package. The process helps in determining parameters for its sterilization process to ensure safety and ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370


Asia Colonoscopy Devices Market - Opportunities and Forecasts, 2014 - 2020

Colonoscopy devices are used for internal examination of large intestine or colon as well as rectum. These devices come with a small camera connected to a flexible tube. Furthermore, the ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850


European Hyperspectral Imaging Market - Opportunities and Forecasts, 2015 - 2020

Hyperspectral Imaging (HSI) is an imaging technique for collection and processing information across electromagnetic spectrum. The prime function of HSI is to form a spectrum of each pixel of image ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370


Global Nutraceutical Ingredients market (type, application, geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Opportunities, Segmentation, Forecast, 2007 - 2017

Nutraceutical ingredients are chemical, natural bioactive compounds that possess disease preventing, health promoting and medicinal properties. These are primarily used in functional foods and dietary supplements. Nutraceutical ingredient market is ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370


North American Laboratory Information System (LIS) Market - Opportunities and Forecasts, 2015 - 2020

Laboratory information system (LIS) is a system designed to manage data and information in medical related laboratories. It enables users to store, modify, retrieve, and record laboratory data. The information ...

July 2017  |   Price:$ 3390    | Pre Book Price:$ 3390


2017 © Copyright Big Market Research

View Pricing >>